Development, Production, and Characterization of Hepatitis B Subviral Envelope Particles as a Third-Generation...

Area of Science:

• Virology
• Vaccinology
• Biotechnology

Background:

• Hepatitis B virus (HBV) infection remains a significant global health concern.
• Current HBV vaccines, primarily derived from yeast, fail to induce adequate immunity in approximately 10% of recipients.
• There is a need for improved HBV vaccine strategies to overcome non-responsiveness.

Purpose of the Study:

• To develop and characterize a novel hepatitis B vaccine candidate.
• To create a stable Chinese hamster ovary (CHO-K1) recombinant cell line for producing hepatitis B subviral envelope particles (HBV-SVPs).
• To evaluate the immunogenicity and efficacy of the novel HBV-SVPs.

Main Methods:

• Development of a stable CHO-K1 cell line for HBV-SVP production.
• Utilizing Western blot and immunogold electron microscopy for particle characterization (size, morphology, composition).
• Implementing immunization protocols to assess immunogenicity and antibody-mediated viral binding inhibition.

Main Results:

• Successfully developed a stable CHO-K1 cell line secreting HBV-SVPs.
• Characterized HBV-SVPs containing S, M, and L surface glycoproteins.
• Demonstrated the potential for inducing antibodies capable of recognizing the HBV-hepatocyte binding site.

Conclusions:

• The novel HBV-SVP vaccine candidate, produced in CHO-K1 cells, represents a promising next-generation approach for hepatitis B prevention.
• This strategy may overcome the limitations of current vaccines, potentially improving immune response rates.
• Further studies are warranted to confirm the clinical efficacy of this new vaccine platform.